HealthcareServices

Global Gestational Diabetes Market Forecast 2026–2035: Long-Term Growth Insights

February 27, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the gestational diabetes market from 2026–2035 with trusted insights from The Business Research Company

What size range is anticipated for the Gestational Diabetes Market from 2026 to 2030?

The gestational diabetes market has experienced substantial growth in recent years. This market is anticipated to expand from $9.11 billion in 2025 to $9.93 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.9%. Historically, this growth has been fueled by factors such as increasing obesity rates, a rise in pregnancies among older mothers, the availability of early diabetes screening programs, the expansion of prenatal care services, and a greater awareness of pregnancy complications.

The gestational diabetes market is projected to experience substantial expansion in the coming years, reaching a valuation of $13.85 billion by 2030, driven by a compound annual growth rate (CAGR) of 8.7%. This anticipated growth throughout the forecast period is primarily due to factors such as an increase in gestational diabetes prevalence, broader adoption of digital health monitoring, advancements in prenatal diagnostics, a greater emphasis on preventive maternal care, and supportive healthcare policies. Key developments anticipated during this timeframe include an uptick in the use of blood glucose monitoring, a rise in insulin therapy for pregnant individuals, an increasing focus on managing the disease through lifestyle modifications, the expansion of prenatal screening initiatives, and heightened awareness regarding maternal health.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20818&type=smp

What Drivers Are Affecting Demand In The Gestational Diabetes Market?

The increasing obese population is anticipated to propel the growth of the gestational diabetes market in the future. This population consists of individuals with a body mass index (BMI) of 30 or higher, indicating excess body fat that poses considerable health risks. The rise in the obese population is attributed to a combination of sedentary lifestyles, increased consumption of high-calorie, processed foods, genetic predispositions, and limited access to healthy food and exercise options. Gestational diabetes treatment is critical for the obese population because their heightened risk of insulin resistance and significant weight gain during pregnancy can lead to complications for both mother and baby if not managed. For instance, in May 2025, according to the Office for Health Improvement and Disparities, a UK-based government body, an estimated 64.5% of adults aged 18 and over in England were overweight or living with obesity from 2023 to 2024, an increase from 64.0% in 2022 to 2023. Therefore, the expanding obese population is driving the gestational diabetes market.

Which Segments Are Gaining Traction In The Gestational Diabetes Market?

The gestational diabetes market covered in this report is segmented –

1) By Type: Type A1, Type A2, Other Types

2) By Treatment: Monitoring, Drug Treatment, Non-pharmacological Treatment

3) By Administration: Oral, Intravenous, Other Administrations

4) By End User: Hospitals, Clinics, Home Care Settings, Diagnostic Centers

Subsegments:

1) By Type A1: Diet-Controlled Gestational Diabetes, Exercise-Controlled Gestational Diabetes

2) By Type A2: Insulin-Controlled Gestational Diabetes, Oral Medication-Controlled Gestational Diabetes

3) By Other Types: Pre-Gestational Diabetes, Gestational Diabetes With Complications

How Are Emerging Trends Affecting The Progression Of The Gestational Diabetes Market?

Key players within the gestational diabetes market are prioritizing the development of technologically advanced products, including diagnostic kits for gestational diabetes, aiming to offer swift, accurate, and user-friendly approaches for early detection. A diagnostic kit for gestational diabetes functions as a medical device employed to gauge blood glucose levels and pinpoint atypical glucose tolerance in pregnant women, thereby aiding in the early identification and management of the condition. As an illustration, in August 2024, DirectSens GmbH, an Austria-based biotechnology company, launched the XpressGT RUO kit, a diagnostic solution specifically created to diagnose gestational diabetes, endometriosis, insulin resistance, and liver disease. It precisely measures 2-hydroxybutyrate (2-HB) levels present in venous blood, which the liver naturally produces during its normal operations. Elevated 2-HB levels are connected to increased reductive stress, which is associated with various endocrine and obesity-related disorders, such as insulin resistance. This kit is compatible with any existing clinical analyzer and delivers results in merely 8 minutes, offering a rapid and effective diagnostic alternative.

Who Are The Major Companies Operating In The Gestational Diabetes Market?

Major companies operating in the gestational diabetes market are Sanofi S.A., Abbott Laboratories, Eli Lilly and Company, Novo Nordisk A/S, Becton Dickinson and Company, Dexcom Inc, Biocon Limited, Ascensia Diabetes Care Holdings AG, Roche Diabetes Care, Medtronic plc, Insulet Corporation, Tandem Diabetes Care Inc, Ypsomed Holding AG, Beta Bionics Inc, Bigfoot Biomedical Inc, Glooko Inc, Philips Healthcare, Sun Pharmaceutical Industries Ltd, Takeda Pharmaceutical Company Ltd, Pfizer Inc, Novartis AG, Adocia SA, Daiichi Sankyo Company Ltd

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/gestational-diabetes-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Gestational Diabetes Market?

North America was the largest region in the gestational diabetes market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gestational diabetes market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Gestational Diabetes Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20818&type=smp

Browse Through More Reports Similar to the Global Gestational Diabetes Market 2026, By The Business Research Company

Diabetes Care Devices Market 2026

https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-market

Type 1 Diabetes Market Report 2026

https://www.thebusinessresearchcompany.com/report/type-1-diabetes-global-market-report

Insuman Market Report 2026

https://www.thebusinessresearchcompany.com/report/insuman-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795